NCT00345683View on ClinicalTrials.gov

Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 12 to 15 Months of Age.

PHASE3CompletedINTERVENTIONAL
Enrollment

4,021

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

September 30, 2008

Study Completion Date

November 30, 2008

Conditions
Haemophilus Influenzae Type bNeisseria Meningitidis
Interventions
BIOLOGICAL

GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine combined (792014)

Booster dose by intramuscular injection

BIOLOGICAL

PedvaxHIB

Booster dose by intramuscular injection

BIOLOGICAL

Prevnar

Booster dose by intramuscular injection

BIOLOGICAL

M-M-R II

Single dose by subcutaneous injection

BIOLOGICAL

Varivax

Single dose by subcutaneous injection

Trial Locations (57)

13210

GSK Investigational Site, Syracuse

13413

GSK Investigational Site, New Hartford

14850

GSK Investigational Site, Ithaca

15090

GSK Investigational Site, Wexford

15217

GSK Investigational Site, Pittsburgh

15220

GSK Investigational Site, Pittsburgh

15227

GSK Investigational Site, Pittsburgh

15236

GSK Investigational Site, Pittsburgh

15241

GSK Investigational Site, Pittsburgh

16125

GSK Investigational Site, Greenville

16505

GSK Investigational Site, Erie

27609

GSK Investigational Site, Raleigh

29406

GSK Investigational Site, Charleston

33324

GSK Investigational Site, Plantation

35205

GSK Investigational Site, Birmingham

35244

GSK Investigational Site, Birmingham

37660

GSK Investigational Site, Kingsport

40004

GSK Investigational Site, Bardstown

40503

GSK Investigational Site, Lexington

44121

GSK Investigational Site, Cleveland

GSK Investigational Site, South Euclid

44512

GSK Investigational Site, Boardman

44718

GSK Investigational Site, Canton

44720

GSK Investigational Site, North Canton

49024

GSK Investigational Site, Portage

49120

GSK Investigational Site, Nies

49127

GSK Investigational Site, Stevensville

50263

GSK Investigational Site, Waukee

50266

GSK Investigational Site, West Desmoines

53792

GSK Investigational Site, Madison

54449

GSK Investigational Site, Marshfield

55108

GSK Investigational Site, Saint Paul

71111

GSK Investigational Site, Bossier City

72015

GSK Investigational Site, Benton

72205

GSK Investigational Site, Little Rock

72401

GSK Investigational Site, Jonesboro

80303

GSK Investigational Site, Boulder

80501

GSK Investigational Site, Longmont

84041

GSK Investigational Site, Layton

84057

GSK Investigational Site, Orem

84062

GSK Investigational Site, Pleasant Gorve

84088

GSK Investigational Site, West Jordan

84095

GSK Investigational Site, South Jordan

84109

GSK Investigational Site, Salt Lake City

84121

GSK Investigational Site, Salt Lake City

84405

GSK Investigational Site, Ogden

89104

GSK Investigational Site, Las Vegas

91790

GSK Investigational Site, West Covina

92708

GSK Investigational Site, Fountain Valley

93637

GSK Investigational Site, Madera

93710

GSK Investigational Site, Fresno

93726

GSK Investigational Site, Fresno

93901

GSK Investigational Site, Slinas

208 463 3126

GSK Investigational Site, Nampa

02130

GSK Investigational Site, Boston

04530

GSK Investigational Site, Mexico City

06720

GSK Investigational Site, Mexico City

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY